Search the Newsreel

Anteris Technologies Global Corp (AVR) Stock News Today

This article provides current stock information for Anteris Technologies Global Corp (AVR), including its stock price, market capitalization, and a note about upcoming news. As of the close on August 7th, the stock was trading at $8.910, up 6.58%. The article indicates that more …

VeriSign, Inc (VRSN) Stock News Today

This article from TradingKey provides current stock information for VeriSign, Inc (VRSN), including its real-time price, market capitalization, and P/E ratio. It indicates that more news, earnings reports, and analyst ratings for VRSN will be available soon. The page serves as a hub for …

STERIS plc (Ireland) (STE) Stock Forecasts

STERIS plc (STE) is a medical technology company specializing in sterilization services and infection prevention, holding a leading position in contract sterilization. A recent Morningstar report highlights the company's healthy fundamentals, which are enabling accelerated share repurchases and increased investment. The report provides a …

Is Aeris Resources (ASX:AIS) Rewriting Its Growth Story With Higher 2027 Capital And Exploration Spend?

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Anteris Technologies Global (AVR) Projected to Announce Earnings on Friday

Anteris Technologies Global (AVR) is projected to announce its Q2 2026 earnings before the market opens on Friday, August 14th, with analysts expecting a loss of $0.2073 per share and revenue of $1.50 million. The company missed estimates in its previous quarter and currently …

Xeris Biopharma (XERS) Stock Jumps On Record Revenue Despite Wider Losses

Jefferies upgrades Arteris stock rating on profitability outlook

Jefferies has upgraded Arteris Inc. (NASDAQ:AIP) stock rating from Hold to Buy and increased its price target to $50.00, citing increased comfort with the company's path to non-GAAP profitability. The firm expects Arteris to achieve profitability by Q4 2026, driven by an 88% gross …

Needham Maintains Steris PLC(STE.US) With Hold Rating

Needham has reiterated its Hold rating on Steris PLC (STE.US). This indicates that the analyst firm is advising investors to maintain their current position in the stock without buying or selling.

STERIS plc 2026: Revenue $1.49B, EPS $2.04— 10-Q Summary

STERIS plc (STE) reported its 2026 quarterly results with revenue of $1.49 billion and diluted EPS of $2.04, marking significant year-over-year growth in both metrics. The revenue increase of 7.3% was driven by higher volume and pricing, especially in Healthcare and Life Sciences, with …

STERIS plc (NYSE: STE) lifts Q1 2027 revenue to $1.49B, EPS hits $2.04

Ameris Bancorp Q2 FY26 net income drops 53.19% to $51.4 million; net interest margin widens 11 basis points to 3.88%

Ameris Bancorp reported a significant drop in Q2 FY26 net income to $51.4 million, a 53.19% decrease, primarily due to an $82.5 million litigation expense accrual. Despite this, the company saw an 8.89% increase in tax-equivalent net interest income and an 11 basis point …

Ameris Bancorp Q2 2026: Revenue $365.6M, Net income $51.4M, EPS $0.77— 10-Q Summary

Ameris Bancorp reported its second-quarter 2026 results, showing total revenue of $365.6 million and diluted EPS of $0.77. The net income attributable to common shareholders was $51.4 million, a decrease from the prior year's second quarter. The report highlighted a 5.1% year-over-year revenue increase …

UBS Adjusts Price Target on STERIS to $270 From $275, Maintains Buy Rating

UBS has adjusted its price target for STERIS (NYSE: STE) to $270, down from $275, while reaffirming a Buy rating on the stock. This revision comes as analysts reassess the company's valuation. Despite the slight reduction in the price target, UBS continues to recommend …

Arteris (AIP) Grew Revenue And Named A New CFO, Is It Still Undervalued?

Amerisafe Inc (AMSF) Earnings Forecast: Future EPS & Revenue Growth Estimates

Narrow-Moat Steris' Recurring Revenue and Margin Improvement Create Opportunistic Outlook

Steris, a narrow-moat company, is a leading provider of sterilization products and services in healthcare. Recent acquisitions have expanded its portfolio, positioning it as a "one-stop shop" for outpatient settings. The company's focus on recurring revenue and margin improvements suggests an opportunistic outlook, further …

Verisk Analytics (VRSK) Balances Lower Q2 Earnings With Buybacks and Dividends: What Story Does That Tell?

Verisk Analytics reported higher Q2 2026 sales but lower net income, yet reaffirmed full-year revenue guidance and an annual dividend of US$2.00 per share. The company has continued significant share buybacks totaling over US$7.27 billion since 2022. Despite these efforts and a leadership change, …

STERIS plc (STE) Stock Price, News, Quote & History

This article provides a comprehensive overview of STERIS plc (STE) stock, including its current price, dividend information, key financial metrics, and company profile. It details the company's segments in Healthcare, Applied Sterilization Technologies, and Life Sciences, and offers performance benchmarks against the S&P 500, …

Ameriserv Financial Inc (ASRV) Stock News Today

This article provides current stock information for Ameriserv Financial Inc (ASRV), including its market cap, P/E ratio, and recent stock performance. It notes that more news will be available soon and offers contact information for content collaboration and user feedback.

STERIS plc (STE) Stock News Today

This page provides current stock information for STERIS plc (STE), including its market price, market capitalization, P/E ratio, and recent performance. It indicates that more news and earnings updates for the company will be available soon. The platform, TradingKey, offers general investment information and …

Verisk Analytics CEO Lee Shavel Sells 2,500 Shares for $550,000

Verisk Analytics CEO Lee Shavel sold 2,500 shares of the company's common stock for $550,000 on July 29, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025 and is not considered a cause for concern for investors. …

State Street Corporation (ABCB) reports 3.49M Ameris Bancorp shares, a 5.2% holding

State Street Corporation has reported a beneficial ownership of 3,490,328 shares in Ameris Bancorp (ABCB), which constitutes a 5.2% stake in the company. The filing indicates that State Street holds shared voting power over 496,338 shares and shared dispositive power over all 3,490,328 shares, …

Sei Investments Co. Increases Holdings in AMERISAFE, Inc. $AMSF

Sei Investments Co. significantly increased its stake in AMERISAFE, Inc. (NASDAQ:AMSF) by 125% in the first quarter, now owning 138,584 shares valued at $4.6 million. This comes as institutional investors hold a substantial 97.41% of the company. Despite the increased institutional interest, analyst sentiment …

Xeris Biopharma Holdings, Inc. 2026: Revenue $92.1M, EPS ($0.18) — 10-Q Summary

Xeris Biopharma Holdings, Inc. reported its 2026 quarterly results with revenue reaching $92.1 million, an increase of 28.7% year-over-year. Despite the revenue growth, the company recorded a net loss of ($31.1M) and a diluted EPS of ($0.18), driven by higher product sales and increased …

Arteris, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:AIP) 2026-08-07

Projeções de Resultados: VeriSign, Inc (VRSN) — LPA e Crescimento de Receita

Notícias das Ações da Verisk Analytics Inc (VRSK)

Steris Earnings: Healthy Fundamentals Allow for Accelerated Repurchases and More Investment

STERIS (STE) Stock Looks Near Fair Value After $600 Million Expansion

Adheris Health Ltd (ASX: AHE) Share Price Update: Stock Declines as Health Care Sector Faces Pressure

L1 Capital Pty Ltd Sells 480,608 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock

L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global (NASDAQ:AVR) stock for approximately $3.99 million on August 4th, reducing its direct ownership by 7.87% to 5.63 million shares. This sale is part of a series of transactions by L1 Capital Pty Ltd …

Arteris | 10-Q: Quarterly report

This article is a quarterly report (Form 10-Q) filed by Arteris. It provides a formal regulatory update on the company's financial performance and operations for the specified quarter.

Xeris Biopharma Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary

Xeris Biopharma Holdings, Inc. has released its earnings summary for the quarter that concluded on June 30. The report is provided by Refinitiv and is available to TradingView users with unlimited access to news articles.

Xeris Pharmaceuticals’ Earnings Call Highlights Growth Momentum

Key Points Interested in Xeris Biopharma Holdings, Inc.? Here are five stocks we like better. Xeris Biopharma's second-quarter revenue rose 29% year over year to $92.1 million, driven by a 34% increase in net product revenue. Adjusted EBITDA grew more than 50% to $19.3 …

Arteris, Inc. (AIP) Stock Price, News, Quote & History

This article provides comprehensive financial data for Arteris, Inc. (AIP), including its stock price, historical performance, key statistics, and analyst ratings. It also offers an overview of the company's semiconductor IP solutions and its market presence. The stock closed at $31.62, up 2.23%, but …